ITRM20030363A0 - COMPOSITIONS INCLUDING 3, 5DIIODOTYRONINE AND DIESSE PHARMACEUTICAL USE. - Google Patents

COMPOSITIONS INCLUDING 3, 5DIIODOTYRONINE AND DIESSE PHARMACEUTICAL USE.

Info

Publication number
ITRM20030363A0
ITRM20030363A0 IT2003RM000363A ITRM20030363A ITRM20030363A0 IT RM20030363 A0 ITRM20030363 A0 IT RM20030363A0 IT 2003RM000363 A IT2003RM000363 A IT 2003RM000363A IT RM20030363 A ITRM20030363 A IT RM20030363A IT RM20030363 A0 ITRM20030363 A0 IT RM20030363A0
Authority
IT
Italy
Prior art keywords
diesse
compositions including
pharmaceutical use
pharmaceutical
compositions
Prior art date
Application number
IT2003RM000363A
Other languages
Italian (it)
Inventor
Fernando Goglia
Antonia Lanni
Maria Moreno
Assunta Lombardi
Original Assignee
Fernando Goglia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fernando Goglia filed Critical Fernando Goglia
Priority to IT000363A priority Critical patent/ITRM20030363A1/en
Publication of ITRM20030363A0 publication Critical patent/ITRM20030363A0/en
Priority to PCT/IT2004/000402 priority patent/WO2005009433A1/en
Publication of ITRM20030363A1 publication Critical patent/ITRM20030363A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
IT000363A 2003-07-24 2003-07-24 COMPOSITIONS INCLUDING 3THIODOTYRONIN AND PHARMACEUTICAL USE OF THEM. ITRM20030363A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT000363A ITRM20030363A1 (en) 2003-07-24 2003-07-24 COMPOSITIONS INCLUDING 3THIODOTYRONIN AND PHARMACEUTICAL USE OF THEM.
PCT/IT2004/000402 WO2005009433A1 (en) 2003-07-24 2004-07-22 Use of 3,5 diiodothyronine as regulators of lipid metabolism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000363A ITRM20030363A1 (en) 2003-07-24 2003-07-24 COMPOSITIONS INCLUDING 3THIODOTYRONIN AND PHARMACEUTICAL USE OF THEM.

Publications (2)

Publication Number Publication Date
ITRM20030363A0 true ITRM20030363A0 (en) 2003-07-24
ITRM20030363A1 ITRM20030363A1 (en) 2005-01-25

Family

ID=29765933

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000363A ITRM20030363A1 (en) 2003-07-24 2003-07-24 COMPOSITIONS INCLUDING 3THIODOTYRONIN AND PHARMACEUTICAL USE OF THEM.

Country Status (2)

Country Link
IT (1) ITRM20030363A1 (en)
WO (1) WO2005009433A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7504435B2 (en) 2001-01-31 2009-03-17 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method for stimulating weight loss and/or for lowering triglycerides in patients
EP2428516A1 (en) 2003-11-19 2012-03-14 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
MX2007014502A (en) 2005-05-26 2008-02-07 Metabasis Therapeutics Inc Thyromimetics for the treatment of fatty liver diseases.
CA2679402A1 (en) 2007-02-27 2008-09-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome
EP2068858A1 (en) * 2007-05-16 2009-06-17 Université Joseph Fourier New pharmaceutical compositions comprising diiodothyronine and their therapeutic use
EP1992341A1 (en) * 2007-05-16 2008-11-19 Université Joseph Fourier New pharmaceutical compositions comprising a thyroid hormon and their therapeutic use
WO2008149379A2 (en) 2007-06-06 2008-12-11 Torrent Pharmaceuticals Ltd. Novel compounds
US20120065267A1 (en) * 2010-09-09 2012-03-15 T*Amine, Llc Compositions including 3,5-l-t2 and methods of use thereof
US20130005814A1 (en) * 2011-07-01 2013-01-03 Thomas Najarian Methods and compositions for facilitating weight loss by administration of thyroid hormones
CN108101851A (en) 2012-09-17 2018-06-01 马德里加尔制药公司 The method of synthetic thyroid hormone analogs and its polymorph
AU2017346871B2 (en) 2016-10-18 2023-08-03 Madrigal Pharmaceuticals, Inc. Methods of treating liver disorders or lipid disorders with a THR-beta agonist
JP2020500199A (en) 2016-11-21 2020-01-09 バイキング・セラピューティクス・インコーポレイテッド Methods of treating glycogen storage disease
WO2018226604A1 (en) 2017-06-05 2018-12-13 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
US11787828B2 (en) 2018-03-22 2023-10-17 Viking Therapeutics, Inc. Crystalline forms and methods of producing crystalline forms of a compound

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2950315A (en) * 1956-06-18 1960-08-23 Baxter Laboratories Inc Production of 3, 5-diiodothyronine
FR2197577A1 (en) * 1972-08-30 1974-03-29 Ind Chimi Ue Sa Hypocholesterolaemic, antiatheroma agents - 3,5-diiodo-4-(3-iodo-4-alkoxy-carbonyl phenoxy) phenylalkanoic acids, esters and salts
FR2501505A1 (en) * 1981-03-11 1982-09-17 Ana Laboratoires NOVEL MEDICINES FOR THE TREATMENT OF 3,5-DIIODO-3'-ISOPROPYL-THYROACETIC ACID-BASED HYPERLIPIDEMIA AND HYPERCHOLESTEROLEMIMIA
DE4026600A1 (en) * 1990-08-23 1992-02-27 Henning Berlin Gmbh AGENTS FOR TSH SUPPRESSION AND TREATMENT OF STRUMA
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
GB9401879D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401891D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9828442D0 (en) * 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
US6747048B2 (en) * 2002-05-08 2004-06-08 Bristol-Myers Squibb Company Pyridine-based thyroid receptor ligands

Also Published As

Publication number Publication date
WO2005009433A1 (en) 2005-02-03
ITRM20030363A1 (en) 2005-01-25

Similar Documents

Publication Publication Date Title
ITMI20031570A1 (en) COMPOSITION FOR DIETARY, PHARMACEUTICAL OR COSMETIC USE
ITTO20010005A1 (en) PHARMACEUTICAL FORMULATION.
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
NO20052306D0 (en) Dispersible pharmaceutical compositions.
ITTO20000779A0 (en) PHARMACEUTICAL COMPOSITIONS.
RS50660B (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
DK1263720T3 (en) Acetidine derivatives, their preparation, and pharmaceutical compositions containing the same
BRPI0407755B1 (en) catalytic composition, preparation and use
BR0115810B1 (en) surfactant-free cosmetic, dermatological and pharmaceutical compositions.
NO20052496D0 (en) Selected CGRP antagonists, methods for their preparation and use thereof as drugs.
IL174479A (en) Hemiasterlin derivatives, pharmaceutical compositions comprising the same and uses thereof
NL1025404A1 (en) Pyrazolo-triazine compounds and use thereof.
IL175252A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
HK1103073A1 (en) Substituted diaza-spiro-[5.5-undecane derivatives and their use as neurokinin antagonists
PL394604A1 (en) Vinylazocycloalkanyl derivative, the use thereof and pharmaceutical composition
ITRM20030363A0 (en) COMPOSITIONS INCLUDING 3, 5DIIODOTYRONINE AND DIESSE PHARMACEUTICAL USE.
ITMI20031396A1 (en) COMPOSITION FOR PHARMACEUTICAL OR DIETETIC OR COSMETIC USE WITH ANTIOXIDANT ACTIVITY.
NO20052478D0 (en) Vitamin D analogues, compositions comprising the analogues and their use.
BR0208566B1 (en) Beta-Carboline Derivatives, Their Use, and Pharmaceutical Composition
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
BRPI0313645A2 (en) inhalation compositions with high drug ratios.
IT1318401B1 (en) N-DESACETYLTHIOCOLCHYCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN.
ITRM20020119A0 (en) COMPOSITIONS CONTAINING PLGF FOR PHARMACEUTICAL AND COSMETIC USE.
EE200300465A (en) Pharmaceutical compositions based on pyridoindolone derivatives
ITMI20020872A0 (en) HYPERFORIN DERIVATIVES, THEIR USE AND FORMULATIONS THAT CONTAIN THEM